clinical trial · NCT06012656
Prospective Study for the Evaluation of the Cementless Anatomic Femoral Stem Minimax -Launay
Medacta International SA·—·active not recruiting·n = 100
Primary OsteoarthritisSecondary OsteoarthritisTraumatic ArthritisRheumatoid ArthritisCongenital Hip DysplasiaAvascular NecrosisFracture; Femur, HeadMiniMAX
brief summary
This is a post-marketing surveillance on MiniMAX Stem
started
Jan 2, 2019
primary completion
Jan 2, 2029
completion
Jan 2, 2031
last updated
Sep 29, 2025
official title
Prospective, Multricentre, Non Controlled, Non-randomized, Open Study for the Evaluation of the Cementless Anatomic Femoral Stem MiniMAX
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol